- Home
- CRTO vs NKTR Comparison
CRTO vs NKTR Comparison
Compare CRTO & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRTO
- NKTR
- Stock Information
- Founded
- CRTO 2005
- NKTR 1990
- Country
- CRTO France
- NKTR United States
- Employees
- CRTO N/A
- NKTR N/A
- Industry
- CRTO Advertising
- NKTR Biotechnology: Pharmaceutical Preparations
- Sector
- CRTO Consumer Discretionary
- NKTR Health Care
- Exchange
- CRTO Nasdaq
- NKTR Nasdaq
- Market Cap
- CRTO 1.2B
- NKTR 1.2B
- IPO Year
- CRTO 2013
- NKTR 1994
- Fundamental
- Price
- CRTO $21.07
- NKTR $57.96
- Analyst Decision
- CRTO Buy
- NKTR Strong Buy
- Analyst Count
- CRTO 9
- NKTR 6
- Target Price
- CRTO $39.11
- NKTR $91.67
- AVG Volume (30 Days)
- CRTO 458.4K
- NKTR 1.2M
- Earning Date
- CRTO 10-29-2025
- NKTR 11-06-2025
- Dividend Yield
- CRTO N/A
- NKTR N/A
- EPS Growth
- CRTO 44.35
- NKTR N/A
- EPS
- CRTO 2.38
- NKTR N/A
- Revenue
- CRTO $1,946,032,000.00
- NKTR $74,934,000.00
- Revenue This Year
- CRTO N/A
- NKTR N/A
- Revenue Next Year
- CRTO $1.84
- NKTR N/A
- P/E Ratio
- CRTO $9.00
- NKTR N/A
- Revenue Growth
- CRTO N/A
- NKTR N/A
- 52 Week Low
- CRTO $20.84
- NKTR $6.48
- 52 Week High
- CRTO $47.27
- NKTR $62.95
- Technical
- Relative Strength Index (RSI)
- CRTO 35.37
- NKTR 65.18
- Support Level
- CRTO $21.30
- NKTR $57.50
- Resistance Level
- CRTO $22.07
- NKTR $62.82
- Average True Range (ATR)
- CRTO 0.67
- NKTR 3.73
- MACD
- CRTO -0.07
- NKTR -0.77
- Stochastic Oscillator
- CRTO 0.86
- NKTR 56.85
About CRTO Criteo S.A.
Criteo SA is an ad-tech company in the digital advertising market. Its technology, allows retailer advertisers to launch multichannel and cross-device marketing campaigns in real time. With real-time return on investment analysis of the ads, the firm's clients can adjust their marketing strategies dynamically. It has two reportable segments: Retail Media and Performance Media. The firm also provides technology allowing retailers to effectively manage their ad inventories and improve yield optimization.
About NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.